Top Markets
#1 ORDI ORDI +46.33%
#2 The White Whale The White Whale +35.01%
#3 pippin pippin +30.07%
#4 Axelar Axelar +27.83%
#5 SATS (Ordinals) SATS (Ordinals) +25.54%
#6 1000SATS (Ordinals) 1000SATS (Ordinals) +24.70%
#7 Walrus Walrus +22.51%
#8 Swarms Swarms +22.12%
#9 tomiNet tomiNet +21.35%
#10 Wojak Wojak +19.76%
Coin of the day
ORDI ORDI
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Classement en actions #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Prix de l'action
$0.00047446
Capitalisation boursière
$82.80
Changement (1 jour)
0.00%
Changement (1 an)
-98.16%
Pays
FR
Échange Neovacs S.A. (ALNEV)

Catégorie

Healthcare
Le prix ALNEV avec la capitalisation boursière de B
Neovacs S.A. Neovacs S.A.
ALNEV
$0.00047446
Capitalisation boursière de Neovacs S.A.(ALNEV)
Capitalisation boursière: $82.80
En April 2026, Neovacs S.A. a une capitalisation boursière de $82.80. Cela fait de Neovacs S.A. la 21228th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Neovacs S.A. du 2010 au 2026
ALNEV par rapport au top 5 des plus populaires stocks
Prix pour ALNEV L’actif B La capitalisation boursière de B Résultats
Neovacs S.A. Neovacs S.A.
$27,697,121 $82.80
NVIDIA NVIDIA
NVDA
$4.834T +5,837,583,786,445.52%
Neovacs S.A. Neovacs S.A.
$23,184,867 $82.80
Alphabet Inc. Alphabet Inc.
GOOG
$4.046T +4,886,558,527,366.32%
Neovacs S.A. Neovacs S.A.
$22,439,280 $82.80
Apple Inc. Apple Inc.
AAPL
$3.916T +4,729,415,033,525.86%
Neovacs S.A. Neovacs S.A.
$17,497,551 $82.80
Microsoft Corporation Microsoft Corporation
MSFT
$3.054T +3,687,871,352,873.25%
Neovacs S.A. Neovacs S.A.
$15,286,009 $82.80
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.668T +3,221,755,841,375.63%